OPK stock forecast
Our latest prediction for OPKO Health, Inc.'s stock price was made on the Jan. 10, 2020 when the stock price was at 1.45$.
In the short term (2weeks), OPK's stock price should underperform the market by -0.67%. During that period the price should oscillate between -7.97% and +11.61%.
In the medium term (3months), OPK's stock price should underperform the market by -6.81%. During that period the price should oscillate between -29.37% and +27.54%.Get email alerts
About OPKO Health, Inc.
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
At the moment the company generates 899M USD in revenues.
On its last earning announcement, the company reported a loss of -0.48$ per share.
The book value per share is 3.23$
Three months stock forecastJan. 10, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|